Skip to main content

CPF III-A PT SPV, LLC's Form 4/A amendment

Amended

P3 Health Partners Inc. (PIII) · filed Oct 4, 2023

Accession no.
0001062993-23-018941
Filed
Oct 4, 2023, 8:18 AM ET
Trade date
Sep 11-13, 2023
Filing delay
23 days
Rule 10b5-1 plan
Not checked
Original filed
Sep 13, 2023

This filing lists 3 non-derivative transactions. Open-market purchases total $685.0K. It was filed 23 days after the trade.

This filing was later replaced by the amendment 0001213900-24-077451 (Sep 10, 2024). Trade tables on this site use the amended version.

This amendment replaces 0001062993-23-017986 (filed Sep 13, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
CPF III-A PT SPV, LLCCIK 000197560010% Owner
CPF III PT SPV, LLCCIK 000197560110% Owner
Chicago Pacific Founders UGP III, LLCCIK 000197565810% Owner
Chicago Pacific Founders GP III, L.P.CIK 000197582810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 11, 2023Class A Common StockPPurchaseAcquired+90,000$2.34F2+$210,22249,575,442Indirect
Sep 12, 2023Class A Common StockPPurchaseAcquired+90,000$2.63F4+$236,52049,665,442Indirect
Sep 13, 2023Class A Common StockPPurchaseAcquired+90,000$2.65F5+$238,22149,755,442Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Includes (i) 69,433.68 shares of Common Stock directly acquired by CPF III PT SPV, LLC ("SPV III") and (ii) 20,566.32 shares of Common Stock directly acquired by CPF III PT SPV-A, LLC ("SPV-A III").

F2

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2.

Referenced by the price of 1 transaction in Table I.

F3

Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III-A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III-A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.

F4

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.9366, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.84, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5.

Referenced by the price of 1 transaction in Table I.

Remarks

This amended Form 4 is filed to correct the number of shares of Class A Common Stock owned by the reporting persons due to a reporting error which first occurred in the Form 4 filed by the reporting persons on August 30, 2023.

Read the full filing on SEC EDGAR (opens in a new tab)